Dr. Huang has been the chief investigator of two clinical trials in Taiwan: a nationwide randomized trial of breast cancer screening using ultrasound and mammography for women aged 40–49; and a multi-center trial of tailored neoadjuvant chemotherapy for breast cancer.
A chief investigator of a global randomized trial of active immunotherapy in metastatic breast cancer and acts as a Steering Committee member in three global trials investigating two anti-Her-2 target therapies: afatinib in metastatic setting and T-DM1 in adjuvant and neoadjuvant setting.
Breast cancer multidisciplinary team, 2013 team award for best clinical service
Award for outstanding teaching material, National Taiwan University Hospital 2010
Outstanding Research, National Taiwan University Hospital 2000
Outstanding Research Award, National Science Council 1999, 2000
Teacher of the year, National Taiwan University Hospital 1998
Research Award, National Science Council 1995
Travel Award, American Society of Clinical Oncology 1992